Biosimilars

Discover the landscape of Biosimilars in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and intelligence on Biosimilars, helping you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Bio-Link Capital Completes Strategic Investment in TYK Medicines – Doubling Down on Bispecific, Trispecific and ADC Antibody Platforms
CompanyDeals

Bio-Link Capital Completes Strategic Investment in TYK Medicines – Doubling Down on Bispecific, Trispecific and ADC Antibody Platforms

Bio-Link Capital announced the completion of a strategic investment in TYK Medicines (HKG: 2410), a macromolecule innovative drug company focused on the development of next‑generation antibody therapeutics, including bispecific antibodies,…

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Company

Innovent Biologics Posts 65% YOY Growth in Q4 2023 with Over RMB 1.6 Billion in Sales

CompanyDrug

Joincare Pharmaceuticals Gets Green Light for Semaglutide Biosimilar Clinical Trial

Company

AbbVie Reports $54.3 Billion in 2023 Revenues Amid Humira Erosion and Segment Variability

CompanyDrug

Sandoz Launches Biosimilar Natalizumab in Germany, Challenging Biogen’s Tysabri

CompanyDeals

Sandoz Strikes Deal to Acquire Coherus Biosimilar for Ophthalmic Treatment

CompanyDrug

Luye Pharma’s Biosimilar Bevacizumab Gets GMP Certification in Brazil

CompanyDeals

Bio-Thera Solutions Grants Macter International Exclusive Rights to Avzivi in Pakistan and Afghanistan

CompanyDrug

Bio-Thera Secures FDA Approval for Avzivi, a Biosimilar to Roche’s Avastin

Show More